Biotangents develop pen-side diagnostic devices to detect infectious diseases in livestock quickly.
Biotangents has raised $2.9M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in November 2024.
Biotangents's investors include Eos, Innovate UK, Scottish Enterprise, Kelvin Capital, Scottish Investment Bank.
Biotangents is headquartered in Penicuik, United Kingdom.
Biotangents develop pen-side diagnostic devices to detect infectious diseases in livestock quickly.
Biotangents is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Biotangents — Funding & Investors." VCBacked, November 28, 2024, https://www.vcbacked.co/company/biotangents. Accessed September 30, 2026.
VCBacked. (2024). Biotangents — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/biotangents
{{cite web |title=Biotangents — Funding & Investors |url=https://www.vcbacked.co/company/biotangents |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated